Statera Biopharma, Inc. (STAB)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
+0.0001 (100.00%)
Mar 5, 2026, 4:00 PM EST
Statera Biopharma Market Cap
Statera Biopharma has a market cap or net worth of $14.52 thousand as of March 6, 2026. Its market cap has increased by 100.01% in one year.
Market Cap
14.52K
Enterprise Value
n/a
Revenue
3.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since July 28, 2021, Statera Biopharma's market cap has decreased from 170.15M to 14.52K, a decrease of -99.99%. That is a compound annual growth rate of -86.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 14.52K | -33.33% |
| Dec 31, 2025 | 21.78K | 200.01% |
| Dec 31, 2024 | 7.26K | -83.33% |
| Dec 29, 2023 | 43.55K | -99.02% |
| Dec 30, 2022 | 4.44M | -93.99% |
| Dec 31, 2021 | 73.82M | -56.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Therapeutic Solutions International | 7.05K |
| NovAccess Global | 6.19K |
| Theralink Technologies | 6.15K |
| Hard to Treat Diseases | 5.82K |
| Evelo Biosciences | 9.49K |
| FluoroPharma Medical | 5.52K |
| LadRx | 5.45K |
| MultiCell Technologies | 5.00K |